Jasper Therapeutics Net Non-Operating Interest Income Expense (Quarterly) Trends

Jasper Therapeutics, Inc. (JSPR)

1.825 +0.04 (+1.96%) USD | NASDAQ | Dec 31, 16:00

1.825 0.00 (0.00%) After-Hours: 19:09

View Net Non-Operating Interest Income Expense (Quarterly) for JSPR.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Net Non-Operating Interest Income Expense (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View Net Non-Operating Interest Income Expense (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Net Non-Operating Interest Income Expense (Quarterly) Benchmarks

Start Trial

Cytokinetics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade
Palatin Technologies, Inc.	Upgrade
Theriva Biologics, Inc.	Upgrade
Oragenics, Inc.	Upgrade